Return on equity ROE
-341 %
Last period ROE
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also IRLAB Therapeutics
Company Analysis
IRLAB A.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
IRLAB A.ST financial analysis by Eyestock methodology
Valuation
IRLAB A.ST valuation using historical relative method
Financials
IRLAB A.ST revenue, earnings, ROE, ROIC and other financials
Statements
IRLAB A.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IRLAB A.ST dividend yield and annual dividend
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
What is ROE of IRLAB Therapeutics ?
IRLAB Therapeutics`s ROE for the last twelve months ended 2024-09-30 is -341 %